CSF analysis of IgH gene rearrangement in CNS lymphoma: Relationship to the disease course

Journal of the Neurological Sciences

Volumn 247, Issue 1, 2006, Pages 39-46

  Ekstein, Dana ^a   Ben Yehuda, Dina ^a   Slyusarevsky, Elena ^a   Lossos, Alexander ^a   Linetsky, Eduard ^a   Siegal, Tali ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

CSF; Cytology; Disease course; Lymphoma; PCR; Primary CNS lymphoma

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BRAIN LYMPHOMA; CANCER PATIENT; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CULTURE; CLINICAL ARTICLE; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DISEASE COURSE; FEMALE; GENE REARRANGEMENT; HUMAN; MALE; NEUROIMAGING; PARENCHYMA; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33746539483     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.03.012     Document Type: Article

References (30)

1. Schumacher M., and Orszagh M. Imaging techniques in neoplastic meningiosis. J Neurooncol 38 (1998) 111-120
2. Kranz B.R., Thiel E., and Thierfelder S. Immunocytochemical identification of meningeal leukemia and lymphoma: poly-l-lysine-coated slides permit multimarker analysis even with minute cerebrospinal fluid cell specimens. Blood 73 (1989) 1942-1950
3. Kranz B.R. Detection of rare malignant cells and their apoptotic fragments in cerebrospinal fluid. Lancet 356 (2000) 1242-1244
4. Lossos I.S., Breuer R., Intrator O., and Lossos A. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients. Cancer 88 (2000) 1599-1604
5. Mavlight G.M., Stuckey S.E., Cabanillas F.F., Keating M.J., Tourtellotte W.W., Schold S.C., et al. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. N Engl J Med 303 (1980) 718-722
6. Redner A., Melamed M.R., and Andreeff M. Detection of central nervous system relapse in acute leukemia by multiparameter flow cytometry of DNA, RNA, and CALLA. Ann N Y Acad Sci 468 (1986) 241-255
7. Dumontet C., Drai J., Bienvenu J., Berard E.N., Thieblemont C., Bouafia F., et al. Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin's lymphoma. Leukemia 13 (1999) 811-817
8. Weller M., Stevens A., Sommer N., Schabet M., and Wietholter H. Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia. Acta Neurol Scand 86 (1992) 129-133
9. Hansen P.B., Kjeldsen L., Dalhoff K., and Olesen B. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement. Acta Neurol Scand 85 (1992) 224-227
10. Potter M.N., Cross N.C., van Dongen J.J., Saglio G., Oakhill A., Bartram C.R., et al. Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review. Leukemia 7 (1993) 1302-1314
11. Potter M.N., Steward C.G., and Oakhill A. The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. Br J Haematol 83 (1993) 412-418
12. Diss T.C., Peng H., Wotherspoon A.C., Isaacson P.G., and Pan L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol 169 (1993) 291-295
13. Achille A., Scarpa A., Montresor M., Scardoni M., Zamboni G., Chilosi M., et al. Routine application of polymerase chain reaction in the diagnosis of monoclonality of B-cell lymphoid proliferations. Diagn Mol Pathol 4 (1995) 14-24
14. Gleissner B., Maurer J., and Thiel E. Detection of immunoglobulin heavy chain genes rearrangements in B-cell leukemias, lymphomas, multiple myelomas, monoclonal and polyclonal gammopathies. Leuk Lymphoma 39 (2000) 151-155
15. Galoin S., Daste G., Apoil P.A., Chollet F., Roda D., Blancher A., et al. Polymerase chain reaction on cerebrospinal fluid cells in the detection of leptomeningeal involvement by B-cell lymphoma and leukaemia: a novel strategy and its implications. Br J Haematol 99 (1997) 122-130
16. Rhodes C.H., Glantz M.J., Glantz L., Lekos A., Sorenson G.D., Honsinger C., et al. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 77 (1996) 543-548
17. Garicochea B., Cliquet M.G., Melo N., del Giglio A., Dorlhiac-Llacer P.E., and Chamone D.A. Leptomeningeal involvement in chronic lymphocytic leukemia identified by polymerase chain reaction in stored slides: a case report. Mod Pathol 10 (1997) 500-503
18. Gleissner B., Siehl J., Korfel A., Reinhardt R., and Thiel E. CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes. Neurology 58 (2002) 390-396
19. Daniel W.W. Biostatistics: a foundation for analysis in the health sciences (1991), John Wiley & Sons, New York
20. Wolpole R.E.M.R.H. Probability and statistics for engineers and scientists (1997), MacMillan Pub. Co.
21. Shoukri M.M., and Pause C.A. Statistical methods for health sciences (1999), CRC Press LLC
22. Tohn N., and Castellan J.R. Nonparametric statistics for the behavioral sciences (1988), MacGraw-Hill Book Company
23. Tohn N.J.R.C. Nonparametric statistics for the behavioral sciences (1988), MacGraw-Hill Book Company
24. Gomori J.M., Heching N., and Siegal T. Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging. J Neurooncol 36 (1998) 55-60
25. Freilich R.J., Krol G., and DeAngelis L.M. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38 (1995) 51-57
26. Hegde U., Filie A., Little R.F., Janik J.E., Grant N., Steinberg S.M., et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk of central nervous system involvement: the role of flow cytometry versus cytology. Blood 105 (2005) 496-502
27. Ferreri A.J., Reni M., and Villa E. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol 11 (2000) 927-937
28. Maloum K., Pritsch O., and Dighiero G. Minimal residual disease detection in B-cell malignancies by assessing IgH rearrangement. Hematol Cell Ther 39 (1997) 119-124
29. Lai R., Rosenblum M.K., and DeAngelis L.M. Primary CNS lymphoma: a whole-brain disease?. Neurology 59 (2002) 1557-1562
30. Kros J.M., Bagdi E.K., Zheng P., Hop W.C., Driesse M.J., Krenacs L., et al. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma. J Neurosurg 97 (2002) 1390-1396